Nasdaq Stocks

The restaurant chain reported Wednesday that its global same-store sales fell 22% in March. Its problems may run deeper than that, writes Stifel analyst Chris O’Cull.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today w

28 out of 30 stocks in the Dow rose Wednesday. Stock in retail giant Walmart was one that finished in the red.

29 out of 30 stocks in the Dow are up in midday trading Wednesday. Stock in retail giant Walmart is the only one in the red.

Ever since the market bottomed and started moving higher, we’ve been working under the assumption that there will be a retest of the lows. The market’s rally hasn’t changed that.

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

The market expects Bed Bath & Beyond (BBBY) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powe

Wall Street expects a year-over-year decline in earnings on lower revenues when Preferred Bank (PFBC) reports results for the quarter ended March 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could

Adtran (ADTN) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2020. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to t

The market expects City Holding (CHCO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor

Wall Street expects a year-over-year decline in earnings on lower revenues when Chemung Financial (CHMG) reports results for the quarter ended March 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that cou

The market expects Bank of America (BAC) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful facto

The market expects Atlassian Corporation PLC (TEAM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a po

Eagle Bancorp (EGBN) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2020. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compa

Wall Street expects a year-over-year decline in earnings on higher revenues when Northwest Bancshares (NWBI) reports results for the quarter ended March 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that

Roche Holding AG RHHBY announced that the FDA has extended the review period of its new drug application (NDA) for its investigational agent risdiplam, currently being developed for the treatment of patients with spinal muscular atrophy (SMA). A decision from the regulatory body

The novel coronavirus outbreak has not only claimed human lives but is also wreaking havoc on the global economy. Companies across the globe are facing unprecedented challenges and taking stringent measures to tackle the crisis. Suspension of production, forced leaves/layoffs an

The coronavirus-led pandemic shook the insurance industry to a great degree. However, one particular category of insurers dealing with auto insurance is enjoying the market’s sweet spot.

Immunomedics, Inc. IMMU announced that the FDA has granted a Fast Track designation to its lead candidate sacituzumab govitecan for the treatment of adult patients with locally advanced or metastatic urothelial cancer (mUC), having received a PD-1/PD-L1 inhibitor and a platinum

It seems to be a wise decision to add Ally Financial ALLY stock to your portfolio now, given the company’s efforts to diversify revenues. Also, restructuring and expansion activities, as well as its strong balance sheet position bode well for the future.Further, analysts are b